Author

Leo Dumjahn

Observed name: Dumjahn, Leo

Institutions: University of Oxford, Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)

Observed institutions: University of Oxford, Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)

ORCID: 0009-0004-3839-4735

Observed ORCID: 0009-0004-3839-4735

OpenAlex ID: A5082586572

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine

2023 · Lennart Brewitz, Leo Dumjahn, et al. · Journal of Medicinal Chemistry · 71

Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies

2025 · Dóra Laczi, Sofia Schönbauer Huamán, et al. · European Journal of Medicinal Chemistry · 9

Thiotemplated Polyketide Chain Fusion and Reductive Cyclization Build the Reactive Butenolide Core of Malleicyprol

2025 · Jonas Fiedler, Leo Dumjahn, et al. · Angewandte Chemie International Edition · 3

Thiotemplated Polyketide Chain Fusion and Reductive Cyclization Build the Reactive Butenolide Core of Malleicyprol

2025 · Jonas Fiedler, Leo Dumjahn, et al. · Angewandte Chemie · 1

Dual-use virulence factors of the opportunistic pathogen Chromobacterium haemolyticum mediate hemolysis and colonization

2025 · Leo Dumjahn, Philipp Wein, et al. · mBio

Dual-use virulence factors of the opportunistic pathogen Chromobacterium haemolyticum mediate haemolysis and colonization

2025 · Leo Dumjahn, Philipp Wein, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 7

Citation count: 84

H-index: 3

I10-index: 1